文献速递肝病

使用定量磁共振成像对代偿期肝硬化患者进行多器官评估

Multi-organ assessment of compensated cirrhosis patients using quantitative magnetic resonance imaging.
PubMed 文献 · J Hepatol · 2018-06-08

研究纳入60例代偿期肝硬化患者、40名健康志愿者和7例失代偿期肝硬化患者,在单次扫描中采用磁共振成像评估肝、脾、肾结构、血流与灌注。结果显示肝T1、肝灌注和肾皮质T1与疾病严重程度及未来肝脏相关结局相关,且无需对比剂。

要点

  • 单次磁共振扫描可同时评估肝硬化患者肝、脾、肾的结构、血流与灌注,无需对比剂。
  • 肝T1、肝灌注和肾皮质T1在代偿期肝硬化发生肝脏相关结局的患者中基线即有显著差异。
  • 随着疾病严重程度增加,肝和脾灌注进行性下降,肾皮质T1降低,心脏指数和肠系膜上动脉血流增加。

核心结论

  • 磁共振成像可在单次扫描中无对比剂地同时评估肝硬化患者的多个器官。
  • 肝T1、肾T1、肝和脾灌注以及肠系膜上动脉血流等磁共振参数与肝脏相关结局风险相关。

研究设计与样本

  • 研究纳入60例代偿期肝硬化患者、40名健康志愿者和7例失代偿期肝硬化患者。
  • 在单次扫描中,磁共振测量包括相位对比磁共振血管血流、动脉自旋标记组织灌注、T1纵向弛豫时间、心率、心脏指数以及肝、脾、肾体积评估。
  • 研究分析了基线磁共振参数与疾病严重程度的关系,并比较了11例(18%)日后发生肝脏相关结局的代偿期肝硬化患者与其余患者的基线磁共振参数差异。

主要发现

  • 在肝脏,疾病进展表现为T1增高(p <0.001),代偿期肝硬化患者肝体积增加(p = 0.006),肝灌注(p <0.001)和脾灌注(p <0.001)进行性下降。
  • 随着疾病严重程度增加,肾皮质T1显著降低,心脏指数和肠系膜上动脉血流增加。
  • 日后发生不良肝脏相关结局的代偿期肝硬化患者,基线肝T1(p = 0.01)、肝灌注(p <0.01)和肾皮质T1(p <0.01)存在显著差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Advancing liver disease results in deleterious changes in a number of critical organs. The ability to measure structure, blood flow and tissue perfusion within multiple organs in a single scan has implications for determining the balance of benefit vs. harm for therapies. Our aim was to establish the feasibility of magnetic resonance imaging (MRI) to assess changes in Compensated Cirrhosis (CC), and relate this to disease severity and future liver-related outcomes (LROs). METHODS: A total of 60 patients with CC, 40 healthy volunteers and 7 patients with decompensated cirrhosis were recruited. In a single scan session, MRI measures comprised phase-contrast MRI vessel blood flow, arterial spin labelling tissue perfusion, T1 longitudinal relaxation time, heart rate, cardiac index, and volume assessment of the liver, spleen and kidneys. We explored the association between MRI parameters and disease severity, analysing differences in baseline MRI parameters in the 11 (18%) patients with CC who experienced future LROs. RESULTS: In the liver, compositional changes were reflected by increased T1 in progressive disease (p <0.001) and an increase in liver volume in CC (p = 0.006), with associated progressive reduction in liver (p <0.001) and splenic (p <0.001) perfusion. A significant reduction in renal cortex T1 and increase in cardiac index and superior mesenteric arterial blood flow was seen with increasing disease severity. Baseline liver T1 (p = 0.01), liver perfusion (p <0.01), and renal cortex T1 (p <0.01) were significantly different in patients with CC who subsequently developed negative LROs. CONCLUSIONS: MRI enables the contemporaneous assessment of organs in liver cirrhosis in a single scan without the requirement for a contrast agent. MRI parameters of liver T1, renal T1, hepatic and splenic perfusion, and superior mesenteric arterial blood flow were related to the risk of LROs. LAY SUMMARY: This study assesses the changes to structure, blood flow and perfusion that occur in the key organs (liver, spleen and kidney) associated with severe liver disease (Compensated Cirrhosis), using magnetic resonance imaging. The magnetic resonance imaging measures which changed with disease severity and were related to negative liver-related clinical outcomes are described.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Bradley CR, Cox EF, Scott RA, et al. Multi-organ assessment of compensated cirrhosis patients using quantitative magnetic resonance imaging. J Hepatol. 2018. PMID: 29886155. doi:10.1016/j.jhep.2018.05.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。